세계의 일렉트로컴피텐트 세포 시장 : 용도별, 세포 유형별, 형질전환 효율별, 포장 형태별, 최종 사용자별, 지역별
Electrocompetent Cells Market, By Application, By Cell Type, By Transformation Efficiency, By Packaging Format, By End User, By Geography
상품코드
:
1741168
리서치사
:
Coherent Market Insights
발행일
:
2025년 03월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
세계의 일렉트로컴피턴트 세포 시장은 2025년 25억 3,000만 달러로 추정되고, 2032년까지 50억 9,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 CAGR 10.5%를 보일 것으로 예측됩니다.
| 보고 범위 |
보고서 세부정보 |
| 기준연도 |
2024년 |
2025년 시장 규모 |
25억 3,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간: 2025-2032년 CAGR: |
10.50% |
2032년 가치 예측 |
50억 9,000만 달러 |
일렉트로컴피텐트 세포는 일렉트로포레이션(세포막에 일시적인 기공을 형성하는 전계에 세포를 노출시키는 프로세스를 포함)에 의해 DNA를 도입하기 위해 준비된 세균 세포입니다. 외래 DNA가 세포에 삽입되어 복제되어 삽입된 DNA의 카피가 만들어집니다. 또한 일렉트로컴피텐트 세포는 유전자 재조합 생물을 제작하는 유전자 공학에도 이용됩니다.
시장 역학:
분자 클로닝 연구의 연구 활동과 자금 제공 활동이 증가하고 있습니다. 컴피덴트 세포는 다양한 생명 공학 절차에서 매우 효율적이므로 컴피덴트 세포 수요를 높일 것으로 예측됩니다.
그러나, 확실한 기술 지식을 가진 숙련된 전문가의 필요성은 예측 기간 동안 세계의 일렉트로컴피턴트 세포 시장의 성장을 방해할 것으로 예상되는 주요 요인 중 하나입니다.
이 조사의 주요 특징
- 이 조사 보고서는 세계의 일렉트로컴피텐트 세포 시장을 상세하게 분석해 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모 및 복합연간 성장률(CAGR%)을 제공합니다.
- 또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안의 매트릭스에 대해서 해설했습니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 발매 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 주요 고찰도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 일렉트로컴피텐트 세포 시장의 주요 기업을 프로파일 하고 있습니다.
- 이 보고서로부터의 통찰은 마케팅 담당자나 기업의 경영진이, 장래의 제품 발매, 유형, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시하는 것을 가능하게 할 것입니다.
- 이 조사 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자를 대상으로 합니다.
- 이해관계자는 세계의 일렉트로컴피텐트 세포 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 분자 클론 연구에 대한 조사 활동과 자금 제공 활동 증가
- 유전자 치료에 대한 투자 증가
- 숙련된 전문가의 부족
- 재조합 DNA 기술의 진보
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- PORTER 분석
- 합병과 인수 시나리오
제4장 일렉트로컴피텐트 세포 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
- COVID-19 역학
- 공급측과 수요측의 분석
- 경제에 미치는 영향
제5장 일렉트로컴피텐트 세포 시장 : 용도별, 2020-2032년
- 클론
- 단백질 발현
- 돌연변이 유발
- 유전체 DNA 라이브러리 구축
- 항체 생산
- 고처리량 스크리닝
- 기타
제6장 일렉트로컴피텐트 세포 시장 : 세포 유형별, 2020-2032년
- 대장균(E. coli)
- 사카로미세스 세레비시에(S. cerevisiae)
- 고초균(B. subtilis)
- 슈도모나스 퓨티다(P. putida)
- 폐렴연쇄상구균(S. pneumoniae)
- 기타
제7장 일렉트로컴피텐트 세포 시장 : 형질전환 효율별, 2020-2032년
제8장 일렉트로컴피텐트 세포 시장 : 포장 형태별, 2020-2032년
제9장 일렉트로컴피텐트 세포 시장 : 최종 사용자별, 2020-2032년
- 제약 및 생명 공학 기업
- 학술연구기관
- 계약연구기관(CRO)
- 기타
제10장 일렉트로컴피텐트 세포 시장 : 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 아프리카
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제11장 경쟁 구도
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- QIAGEN NV
- New England Biolabs, Inc.
- GenScript Biotech Corporation
- Lucigen Corporation
- Takara Bio Inc.
- Delphi Genetics SA
- IBA GmbH
- Scarab Genomics LLC
- Zymo Research Corporation
- Bioline GmbH(Meridian Bioscience)
- SelectScience
- Biosearch Technology
제12장 섹션
JHS
영문 목차
Electrocompetent Cells Market is estimated to be valued at USD 2.53 Bn in 2025 and is expected to reach USD 5.09 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 2.53 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
10.50% |
2032 Value Projection: |
USD 5.09 Bn |
Electrocompetent cells are bacterial cells that have been prepared for the uptake of DNA through electroporation, a process that involves exposing the cells to an electric field that creates temporary pores in the cell membranes. This allows foreign DNA to enter the cell, which can then be incorporated into the cell's own DNA. This technique is commonly used in molecular biology for cloning purposes, and the cells are often used in research and development in the biotechnology and pharmaceutical industries. electrocompetent cells have a wide range of applications, particularly in the field of biotechnology and genetic engineering. here are some of the key applications,.such as cloning, electrocompetent cells are often used in cloning experiments. The foreign DNA is inserted into the cells, which then replicate, producing many copies of the inserted DNA. They are used in the production of proteins. Moreover, electrocompetent cells are used in genetic engineering to create genetically modified organisms. This can be used in agriculture to create crops with desirable traits, or in medicine to create bacteria that produce therapeutic proteins.
Market Dynamics:
There is a rise in research activities and funding activities in molecular cloning studies. This in turn is expected to boost the demand for competent cells, as they are highly efficacious in various biotechnology procedures. This factor is expected to support the growth of the global electrocompetent cells market over the forecast period.
However, the need for skilled professionals with sound technical knowledge is one of the major factors expected to hamper growth of the global electrocompetent cells market over the forecast period.
Key features of the study:
- This report provides in-depth analysis of the global electrocompetent cells market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global electrocompetent cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), SelectScience and Biosearch Technology.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global electrocompetent cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global electrocompetent cells market
Global Electrocompetent Cells Market Detailed Segmentation:
- By Application:
- Cloning
- Protein Expression
- Mutagenesis
- Genomic DNA Library Construction
- Antibody Production
- High-Throughput Screening
- Others
- By Cell Type
- Escherichia coli (E. coli)
- Saccharomyces cerevisiae (S. cerevisiae)
- Bacillus subtilis (B. subtilis)
- Pseudomonas putida (P. putida)
- Streptococcus pneumoniae (S. pneumoniae)
- Others
- By Transformation Efficiency:
- High Efficiency Cells
- Ultra-High Efficiency Cells
- By Packaging Format:
- Tubes
- Plates
- Custom Formats
- By End User:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
- Company Profiles:
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- QIAGEN N.V.
- New England Biolabs, Inc.
- GenScript Biotech Corporation
- Lucigen Corporation
- Takara Bio Inc.
- Delphi Genetics S.A.
- IBA GmbH
- Scarab Genomics LLC
- Zymo Research Corporation
- Bioline GmbH (Meridian Bioscience)
- SelectScience
- Biosearch Technology
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Electrocompetent Cells, By Application
- Market Electrocompetent Cells, By Cell Type
- Market Electrocompetent Cells, By Transformation Efficiency
- Market Electrocompetent Cells, By Packaging Format
- Market Electrocompetent Cells, By End User
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in research activities and funding activities in molecular cloning studies
- Increasing investments in gene therapy
- Lack of skilled professionals
- Advancements in recombinant DNA technology
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Electrocompetent Cells Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Electrocompetent Cells Market , By Application, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Cloning
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Protein Expression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Mutagenesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Genomic DNA Library Construction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Antibody Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- High-Throughput Screening
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. Electrocompetent Cells Market, By Cell Type, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Escherichia coli (E. coli)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Saccharomyces cerevisiae (S. cerevisiae)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Bacillus subtilis (B. subtilis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Pseudomonas putida (P. putida)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Streptococcus pneumoniae (S. pneumoniae)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. Electrocompetent Cells Market, By Transformation Efficiency, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- High Efficiency Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Ultra-High Efficiency Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
8. Electrocompetent Cells Market, By Packaging Format, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Tubes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Plates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Custom Formats
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
9. Electrocompetent Cells Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
10. Electrocompetent Cells Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Transformation Efficiency, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Packaging Format, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- QIAGEN N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- New England Biolabs, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GenScript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lucigen Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Takara Bio Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Delphi Genetics S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- IBA GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Scarab Genomics LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Zymo Research Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bioline GmbH (Meridian Bioscience)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SelectScience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Biosearch Technology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
관련자료
